Rabail earned a Master’s degree in Medical Biotechnology before being awarded the prestigious Fulbright scholarship to pursue a PhD in Neuroscience at Michigan State University, United States. During her doctoral training, she was selected for the NIH-funded Integrated Pharmacological Sciences Training Program, reflecting her strong academic and research potential. Her PhD research focused on investigating the role of neurotensin-expressing neurons in the lateral hypothalamic area and their involvement in the regulation of chronic pain.
Following completion of her PhD in 2024, Rabail relocated to Sydney and joined the Sharpe Lab at The University of Sydney. There, she established advanced In Vivo calcium imaging methodologies, including deep-brain imaging approaches for monitoring neuronal activity in freely behaving animals.
In 2026, Rabail joined the Translational Vectorology Research Unit (TRVU) at Children's Medical Research Institute, where her research focuses on the development of vector-based gene therapies for Parkinson's disease.